Tralokinumab: Unveiling the Promise of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a promising therapy for atopic dermatitis. This specific antibody targets IL-13, a https://mediajx.com/story28090683/text